Reference
MHRA. 5-fluorouracil (intravenous), capecitabine, tegafur: DPD testing recommended before initiation to identify patients at increased risk of severe and fatal toxicity. Drug Safety Update 14: 2-4, No. 3, Oct 2020. Available from: URL: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/928774/Oct-2020-DSU-PDF.pdf
Rights and permissions
About this article
Cite this article
Fluorouracil, capecitabine, tegafur: risk of severe and fatal toxicity. Reactions Weekly 1829, 3 (2020). https://doi.org/10.1007/s40278-020-85593-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-020-85593-0